Guillermina Garcia-Martin

8PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsCentral nervous systemDisease surveillanceNeurology and neuromuscular diseasesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2026
Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real-world clinical practice.

Álvaro Sánchez-Guijo Benavente, Guillermina García Martín, Estuardo Daniel Castro Ruiz

|Nov 20, 2025
Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study.

Teresa Ramirez-Garcia, Pablo Cabezudo-Garcia, Guillermina Garcia-Martin

|Jul 29, 2025
Inflammatory Drug-Resistant Epilepsy Index (IDREI) as a Molecular Compound Biomarker in Focal Epilepsies.

Maria José Aguilar-Castillo, Guillermo Estivill-Torrús, Guillermina García-Martín

|Jun 27, 2024
A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis.

Maria Jose Aguilar-Castillo, Pablo Cabezudo-García, Guillermina García-Martín

|Jan 24, 2024
Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study.

Pedro J Serrano-Castro, Teresa Ramírez-García, Pablo Cabezudo-Garcia

|Aug 22, 2023
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.

Pedro J Serrano-Castro, Juan J Rodríguez-Uranga, Pablo Cabezudo-García

Pageof 2